Muscimol vs Ibotenic Acid: The Real Difference Explained

If you have spent any time looking at Amanita muscaria products, you have probably noticed two compound names that show up on every certificate of analysis: muscimol and ibotenic acid. Both come from the same red-and-white toadstool. Both are listed together on lab reports. Both contribute to the experience. And yet they are, in almost every meaningful way, opposites. One is the calming, dream-inducing reason people seek the mushroom out. The other is the neurotoxic hangover-in-a-molecule that traditional preparation methods exist specifically to get rid of. Knowing which is which is the difference between buying a quality product and buying something that puts you in a CDC report. Here is what each compound actually does, why decarboxylation turns one into the other, and what to look for when you read a label.

What Ibotenic Acid Is

Ibotenic acid is the precursor compound, meaning the mushroom produces it first and most of it. It belongs to a chemical family called isoxazoles, and structurally it resembles glutamate, the brain's main excitatory neurotransmitter. Because of that resemblance, ibotenic acid acts as an agonist at NMDA glutamate receptors and certain metabotropic glutamate receptors, broadly speaking the receptors that crank up neuronal activity rather than calm it down.

This is also why ibotenic acid is genuinely problematic. According to ScienceDirect's toxicology references, ibotenic acid is a powerful neurotoxicant and is used in research specifically as a brain-lesioning agent. In animal studies, scientists inject precise amounts into specific brain regions to destroy targeted cell bodies for experimental purposes. That is not a substance you want hitting your central nervous system in raw, unprocessed form.

In humans, ibotenic acid's effects start within 30 to 60 minutes of ingestion. The early symptoms tend to involve nausea, vomiting, and drowsiness. After the first hour, things shift toward confusion, euphoria, visual and auditory distortions, sensations of floating, and retrograde amnesia. Oral psychoactive doses range from approximately 20 to 100 mg, with about 10 to 20 percent of that ingested ibotenic acid converting to muscimol once inside the body. Most of the desirable effects people associate with ibotenic acid actually come from this conversion.

What Muscimol Is

Muscimol is what ibotenic acid becomes after it loses a carboxyl group, a chemistry process called decarboxylation. The molecule that results is structurally similar to GABA, the brain's main inhibitory neurotransmitter, and it acts as a potent GABA-A receptor full agonist. In plain English, where ibotenic acid pushes the gas pedal of the nervous system, muscimol pumps the brakes.

The clinical literature pegs the oral threshold dose at approximately 6 mg, with the psychoactive range at 8 to 15 mg. As little as one gram of dried Amanita muscaria cap can contain that amount, though potency varies dramatically between specimens. Peak effects occur 1 to 3 hours after oral ingestion and last 4 to 8 hours, with residual effects sometimes lingering up to 24 hours. Estimates from lab data suggest muscimol is roughly ten times more potent than ibotenic acid on a milligram-per-milligram basis.

The experience profile is sedative, dream-like, and dissociative. Users report relaxation, vivid closed-eye imagery, music appreciation that borders on synesthesia, and unusually rich dreams afterward. Pharmacologically, muscimol sits in the same general territory as benzodiazepines and z-drugs like zolpidem, though it is an orthosteric agonist that binds the GABA-A receptor directly rather than modulating it allosterically the way prescription sleep aids do.

The Side-by-Side Comparison

The single most important takeaway from this table: a high-quality Amanita product is one where the ibotenic acid number is as low as possible and the muscimol number is high enough to deliver the labeled dose. A product showing high ibotenic acid and low muscimol has not been properly decarboxylated, and consuming it is essentially eating raw fly agaric.

Decarboxylation: How One Becomes the Other

Decarboxylation is the chemistry that turns ibotenic acid into muscimol. The name describes exactly what happens. The ibotenic acid molecule contains a carboxyl group (a COOH cluster), and decarboxylation removes it as carbon dioxide. What gets left behind is muscimol.

Three things drive this conversion:

1. Heat. Drying mushrooms at low to moderate temperatures (around 175°F or 80°C) over several hours converts a substantial portion of ibotenic acid to muscimol. Higher heat works faster but risks degrading both compounds.
2. Acidic conditions. Simmering Amanita material in water acidified with lemon juice or citric acid (target pH around 3) for 20 to 30 minutes accelerates decarboxylation. This is the basis of most traditional Siberian and Scandinavian preparations.
3. Time. Even at room temperature, dried Amanita slowly continues to decarboxylate over weeks and months. This is why properly aged dried caps are typically more pleasant than freshly dried ones.

There is a persistent online myth that carbonated beverages can reverse decarboxylation and convert muscimol back to ibotenic acid. The claim originated in a 2005 self-published booklet and has been repeated in books and forums ever since. It is chemically incorrect. Carbonation cannot undo the loss of a carboxyl group. Your seltzer is not a problem.

One wrinkle: muscimol can theoretically be converted back to ibotenic acid via an enzyme called glutamate decarboxylase, but this happens at a metabolic level inside cells rather than in your beverage glass.

Why This Matters for Product Safety

The Amanita product industry is full of brands that either do not understand decarboxylation or do not bother to test for it. After the 2024 Diamond Shruumz outbreak, in which 180 people across 34 states reported illness from contaminated mushroom edibles, the FDA issued a December 2024 letter to industry stating that Amanita muscaria, muscimol, and ibotenic acid are not Generally Recognized As Safe for use in conventional food. The letter does not ban the compounds outright, but it does mean food products containing them are now considered adulterated under federal law.

What that means for shoppers: read the certificate of analysis. A reputable Amanita product will list, per serving, the milligrams of muscimol (the active you want) and the milligrams of ibotenic acid (the impurity you do not). The ratio matters more than the total. A gummy with 8 mg muscimol and 0.5 mg ibotenic acid is well-decarboxylated. A gummy with 4 mg muscimol and 6 mg ibotenic acid is closer to raw mushroom material, and it will produce more nausea and unpleasant body load than the muscimol-dominant version.

ShroomSpy's marketplace lists Amanita muscaria products from vendors who publish full certificates of analysis from ISO-certified labs, with both muscimol and ibotenic acid quantified per serving. For the broader regulatory picture, see what is and is not legal in the US mushroom market.

What the Compounds Mean for the Experience

If a person consumes a product heavy in ibotenic acid, the early hours will likely involve nausea, sweating, muscle twitching, and a general unease. The desirable effects (relaxation, dream-like imagery, enhanced sleep) come later as the ibotenic acid converts to muscimol inside the body. That is the worst version of the Amanita experience, and it is what gave fly agaric its scary historical reputation.

If a person consumes a properly decarboxylated, muscimol-dominant product, the experience starts more smoothly. Sedation and warmth come on within an hour or two, the dream-like and dissociative effects build through hours three and four, and the comedown leads into unusually deep sleep with vivid dreams. That is the experience traditional Siberian and Scandinavian users were after when they spent centuries refining preparation techniques. Modern lab-tested extracts replicate it more reliably than wild material, which is one of the few areas where industrial production genuinely improves on traditional practice.

For a deeper dive on the species itself, including identification, history, dosage, and legal status, see the ultimate Amanita muscaria guide.

Legal Status: Both Compounds, Same Story

Neither muscimol nor ibotenic acid is scheduled at the federal level under the Controlled Substances Act, and neither is restricted in any US state except Louisiana, which banned Amanita muscaria itself in 2005 under its hallucinogenic plant law. According to the Legislative Analysis Center's March 2026 fact sheet, both compounds remain legal to possess, distribute, and sell in 49 states and the District of Columbia.

The wrinkle is the FDA's December 2024 letter to industry, which determined that neither compound meets the safety standard for use in conventional food. That action does not criminalize either substance, but it does mean food products like gummies and chocolates marketed as containing them are now considered adulterated under the Federal Food, Drug, and Cosmetic Act. Some brands have pivoted to dietary supplement framing in response. Others have reformulated. The full breakdown of what mushrooms are legal to buy and consume in the US covers the post-FDA-letter landscape in detail.

Conclusion

Muscimol and ibotenic acid look almost identical on a chemistry diagram, differ by a single carboxyl group, and produce dramatically different experiences. Ibotenic acid is the neurotoxic precursor that the mushroom produces in greater quantity and that traditional preparation methods exist specifically to convert. Muscimol is the sedative, dream-state agonist that gives Amanita muscaria its characteristic effects. The chemistry is straightforward once it is laid out. The shopping rule that follows from the chemistry is also simple: high muscimol, low ibotenic acid, third-party tested, with both numbers listed per serving on the certificate of analysis. Anything less is a guessing game.

Ready to take your mycology journey to the next level? Browse our full range of mushroom products at ShroomSpy.com/mushrooms/products and find everything you need to grow, forage, and thrive.

Frequently Asked Questions

Is muscimol stronger than ibotenic acid?

Yes. Lab data summarized in pharmacology references suggests muscimol is approximately ten times more potent than ibotenic acid on a milligram-per-milligram basis. The oral psychoactive dose for muscimol is roughly 6 to 15 mg, while ibotenic acid requires 20 to 100 mg to produce comparable effects, and most of those effects happen because some of the ibotenic acid converts to muscimol after ingestion.

Why is ibotenic acid considered toxic?

Ibotenic acid is an NMDA glutamate receptor agonist with neurotoxic properties. In research settings, it is used as a brain-lesioning agent because precise injections can destroy targeted neurons. At human ingestion doses, it causes nausea, vomiting, sweating, muscle twitching, and unpleasant cognitive effects before any of the desired outcomes appear. Properly prepared Amanita products convert most of the ibotenic acid to muscimol, which dramatically improves the experience.

Can ibotenic acid become muscimol inside the body?

Yes, partially. About 10 to 20 percent of ingested ibotenic acid is decarboxylated to muscimol once inside the body. This is why eating raw or under-decarboxylated Amanita produces some of the sedative effects associated with muscimol, just delayed and accompanied by significantly more nausea and physical unease than a pre-decarboxylated product.

Are muscimol and ibotenic acid legal?

Both compounds are unscheduled at the federal level in the United States and unrestricted in 49 states. Louisiana is the one exception, banning Amanita muscaria itself in 2005. The FDA's December 2024 letter to industry determined that neither compound meets the GRAS safety standard for use in conventional food, which restricts food product use but does not criminalize personal possession.

How can I tell if an Amanita product has been properly decarboxylated?

Read the certificate of analysis. A well-decarboxylated product will show high muscimol content per serving and low ibotenic acid content. A bad ratio (low muscimol, high ibotenic acid) means the source material was either underprocessed or the product was made from raw mushroom material with no real decarboxylation step. If a product does not have a publicly available COA from a third-party ISO-certified lab, treat that as the answer.